Actuate Therapeutics IncACTUNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank10
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Latest
-53.55%
↓ 213% vs avg
Percentile
P10
Near historical low
Streak
1 qtr
Consecutive declineDecelerating
Average
-17.13%
Historical baseline
PeriodValue
Q3 2025-53.55%
Q2 20255.84%
Q1 20253.22%
Q4 202447.84%
Q3 2024-242.19%
Q2 202449.05%
Q1 20244.79%
Q4 20232.24%
Q3 2023-10.20%
Q2 20234.53%
Q1 20230.00%